Companies like Pfizer and Pfizer Medical Systems are among the world’s largest pharmaceutical manufacturers.
The pharmaceuticals they produce help millions of people around the world.
Pfizer sells a range of prescription drugs to a variety of countries, including those in Europe and Africa.
Pfiser’s portfolio includes a wide variety of prescription medications, including the antibiotic cephalosporins, which help to treat tuberculosis.
The drug company’s website says it offers a range “of medicines for a variety, and many, of common conditions.”
Pfizer’s website also says its medicines “are the cornerstone of Pfizer-owned specialty drugs, and Pfiz products are also available through Pfizer pharmacy networks across the world.”
Pfiz has also grown rapidly in the past few years.
Its stock price in 2016 was $39.10, up $10 from 2016.
That’s more than double the company’s price in 2015.
In 2018, Pfiz posted its largest annual profit in a decade.
The company’s sales rose 25 percent year-over-year, to $7.7 billion, and its revenue grew 21 percent to $8.1 billion.
Pfiz’s stock has been rising more than 20 percent annually since 2014.
Pfitz was founded in 1885 by German physician Johann Pfitz, who later became a major figure in the field of medicine.
In the mid-20th century, Pfitz developed the first successful drug, an antiviral drug called cephelin, that has been used for more than 70 years to treat infections, viral diseases and other diseases.
The vaccine was also used in treating tuberculosis.
Pfizers drugs have been used to treat several other conditions, including asthma, diabetes and psoriasis.
The growth in Pfizs business in the last few years has coincided with the rise of a new type of disease: pandemic flu.
A pandemic, which can be a viral disease, can also be caused by viruses.
The influenza pandemic has seen an explosion in cases of coronavirus, a virus that spreads easily and is often spread by people who get the flu.
Pfzs drug portfolio is often used to control the virus by suppressing the immune system.
Pfis drugs also can help treat other diseases that can lead to pneumonia, a potentially deadly condition that can occur in some people.
In some cases, it can cause pneumonia, which is often fatal.
Pfists medicines have also been used in fighting infections, like tuberculosis and other chronic diseases.
Pfys drugs can also treat some types of cancers, and some of the companys own drugs have helped fight a rare form of lung cancer, which some people with the disease develop and have to treat.
In 2019, Pfis drug sales were $5.8 billion, up from $4.3 billion in 2019.
The year before that, sales had declined by 2.5 percent.
By 2018, the company had lost more than 2.4 million employees.
Pfish sales are up about 20 percent over the past decade, thanks to new drugs that have boosted the company in a number of ways.
Its growth has come largely through a series of acquisitions, including a $4 billion deal with AstraZeneca in 2020, which included a pharmaceutical division.
In 2021, Pfish was acquired by Johnson & Johnson.
Its shares rose $5 in 2018 to $41.93, up nearly 30 percent from 2017.
Johnson &s pharmaceutical division now makes drugs to treat a wide range of diseases, including arthritis and heart disease.
Johnson&Johnson, a division of Johnson & amp; Johnson, has also become a powerhouse in the specialty pharmaceuticals market.
It has also been aggressively pursuing a number companies that are growing quickly in the industry, including Pfizer, Pfizer Medicals and Pfis Genomics.
Johnson’s drug portfolio has also made it a strong leader in the drug delivery space.
Its first major foray into this space was with an early-stage drug, a hepatitis C vaccine.
This vaccine is made by GlaxoSmithKline.
This is a big deal because it’s the first hepatitis C vaccines in the U.S. and is designed to be given to people who have not been immunized.
Since then, the vaccine has grown and now has a price tag of about $600 million.
Johnson is also working on a new treatment for the virus that causes the flu, called CephaloVax, which was developed by Pfizer.
It’s being tested by the Centers for Disease Control and Prevention in Atlanta and is expected to be available in 2019 for $3.7 million.
Another big drug deal that Pfish is currently working on is a drug called Zillakre.
This drug is being tested at the Mayo Clinic in Rochester, Minn.
This could mean the company is able to reach a lot of people in rural areas without getting approval from